期刊
LIFE-BASEL
卷 12, 期 6, 页码 -出版社
MDPI
DOI: 10.3390/life12060812
关键词
multiple myeloma; cytogenetics; mutation; molecular genetics; targetable therapies; minimal residual disease
资金
- Paula and Rodger Riney Foundation
Multiple myeloma is a common hematologic malignancy that remains incurable. The development of this disease is closely related to complex genetic aberrations. This review summarizes the knowledge of these genetic aberrations and discusses the application of sensitive molecular techniques in the diagnosis of multiple myeloma.
Multiple myeloma is a disorder of the monoclonal plasma cells and is the second most common hematologic malignancy. Despite improvements in survival with newer treatment regimens, multiple myeloma remains an incurable disease and most patients experience multiple relapses. Multiple myeloma disease initiation and progression are highly dependent on complex genetic aberrations. This review will summarize the current knowledge of these genetic aberrations, how they affect prognosis and the response to treatment, and review sensitive molecular techniques for multiple myeloma workup, with the ultimate goal of detecting myeloma progression early, allowing for timely treatment initiation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据